The salt in the wound being pbt434 and pbt2 are likely going to be worth so much to Dr sinclair that purchasing shares at late 2013 prices would be chump change but Lt holders may have to settle for all time lows
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025